United States · Funded startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Esperion Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$246Mraised across 3 rounds since 2008, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Domain Associates
Alta Partners
Longitude Capital
Asset Management Ventures
Aisling Capital
Arboretum VenturesReported by businesswire.comSEC filing: $17M sold, first sale Apr 2013
Reported by esperion.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Domain AssociatesAlta PartnersAisling CapitalArboretum VenturesLongitude CapitalAsset Management VenturesMissing a round, or an investor who was in one? Tell us.
Esperion Therapeutics's investors include Domain Associates, Alta Partners, Aisling Capital, Arboretum Ventures and Longitude Capital, and 1 more on record.
Esperion Therapeutics has raised $246M across 3 rounds since 2008.
Esperion Therapeutics's most recent round was an Undisclosed round of $190M in Mar 2015.
Its most recent round, $190M in Mar 2015, is also its largest on record.
Esperion Therapeutics's first round on record, in May 2008, was backed by Domain Associates, Alta Partners and Aisling Capital and 1 others.
Esperion Therapeutics's latest named round is an Undisclosed round, in Mar 2015.
Esperion Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·